My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Liquidia Technologies, Inc.

Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Technologies, Inc.
Via GlobeNewswire
Tickers LQDA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.